Philip D. Gregory

2018 - bluebird bio

In 2018, Philip D. Gregory earned a total compensation of $8.7M as Chief Scientific Officer at bluebird bio, a 186% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$223,800
Option Awards$4,737,215
Salary$425,000
Stock Awards$3,284,000
Other$9,250
Total$8,679,265

Gregory received $4.7M in option awards, accounting for 55% of the total pay in 2018.

Gregory also received $223.8K in non-equity incentive plan, $425K in salary, $3.3M in stock awards and $9.3K in other compensation.

Rankings

In 2018, Philip D. Gregory's compensation ranked 908th out of 14,244 executives tracked by ExecPay. In other words, Gregory earned more than 93.6% of executives.

ClassificationRankingPercentile
All
908
out of 14,244
94th
Division
Manufacturing
305
out of 5,762
95th
Major group
Chemicals And Allied Products
92
out of 2,125
96th
Industry group
Drugs
71
out of 1,814
96th
Industry
Biological Products, Except Diagnostic Substances
21
out of 339
94th
Source: SEC filing on April 23, 2019.

Gregory's colleagues

We found four more compensation records of executives who worked with Philip D. Gregory at bluebird bio in 2018.

2018

Nick Leschly

bluebird bio

Chief Executive Officer

2018

Jeffrey Walsh

bluebird bio

Chief Strategy Officer

2018

David Davidson

bluebird bio

Chief Medical Officer

2018

Jason Cole

bluebird bio

Chief Operating and Legal Officer

News

In-depth

You may also like